Keller Rohrback L.L.P. has filed a class action complaint in the United States District Court, Northern District of California against Theranos, Inc. and Walgreens Boot Alliance alleging that Theranos’s “tiny blood test,” that used its proprietary technology “Edison”, did not work. Theranos and Walgreens advertised that the Theranos test could conduct hundreds of blood tests with just a few drops of blood and produce fast results with the highest level of accuracy. But the Theranos tests did not work, often required more than a finger prick of blood, and produced inaccurate results, placing tens of thousands of customers at risk for inaccurate medical diagnosis and/or testing. Theranos tests were available from Theranos or through Theranos Wellness Centers located inside Walgreens primarily in Arizona but also in a few locations in California.
In May, Theranos conceded that its Edison technology was faulty and voided the results from blood-tests it performed from 2014 and 2015. Theranos issued corrected reports—nullifying some results and revising others—to tens of thousands of patients who may have been given incorrect blood-test results.
“Theranos promised three simple things: a less invasive blood test, fast turnaround, and accurate results. The Theranos tests didn’t deliver on any of the three promises,” stated David Copley, an attorney representing the class.
If you purchased a Theranos lab or blood panel directly from Theranos or at any Walgreens location, please call attorneys Mark Samson or Chris Graver at (800) 776-6044 or via email at [email protected] to discuss our investigation and your potential claims against Theranos, Inc. and/or Walgreens Boot Alliance.
Keller Rohrback, with offices in New York, Seattle, Phoenix, Oakland, Missoula, and Santa Barbara, serves as lead and co-lead counsel in class actions throughout the country. Our Complex Litigation Group is proud to offer its expertise to clients nationwide, and our trial lawyers have obtained judgments and settlements on behalf of clients in excess of seven billion dollars.